Memory Scores Limited As Alzheimer's Screening Tool

Share this content:
Memory Scores Limited As Alzheimer's Screening Tool
Memory Scores Limited As Alzheimer's Screening Tool

MONDAY, Dec. 4, 2017 (HealthDay News) -- Low memory scores are an early marker of amyloid positivity, but have limited value as a screening measure for early Alzheimer's disease among persons without dementia, according to a study published online Nov. 29 in JAMA Psychiatry.

Willemijn J. Jansen, Ph.D., from Maastricht University in the Netherlands, and colleagues investigated whether amyloid-β aggregation is associated with cognitive functioning based on analysis of 2,908 participants with normal cognition and 4,133 with mild cognitive impairment (MCI).

The researchers found that among participants with normal cognition, amyloid positivity was associated with low memory scores after age 70 years, but was not associated with low Mini-Mental State Examination (MMSE) scores (P = 0.16). Among patients with MCI, amyloid positivity was associated with both low memory (P < 0.001) and low MMSE (P < 0.001) scores. This association decreased with age. There was limited utility for screening of amyloid positivity in persons with normal cognition or those with MCI based on low cognitive scores.

"Although low memory scores are an early marker of amyloid positivity, their value as a screening measure for early Alzheimer's disease among persons without dementia is limited," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »